Home » Authors » Kim Coghill

Articles by Kim Coghill

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.